中国输血杂志2024,Vol.37Issue(5) :580-585.DOI:10.13303/j.cjbt.issn.1004-549x.2024.05.015

血液制品生产中药用辅料麦芽糖质量可比性研究

Quality of medicinal maltose as a excipient in the production of blood products:a comparative study

杜志如 黄洁 陶迎秋 张慧 罗超 丁亚凌
中国输血杂志2024,Vol.37Issue(5) :580-585.DOI:10.13303/j.cjbt.issn.1004-549x.2024.05.015

血液制品生产中药用辅料麦芽糖质量可比性研究

Quality of medicinal maltose as a excipient in the production of blood products:a comparative study

杜志如 1黄洁 1陶迎秋 1张慧 1罗超 1丁亚凌1
扫码查看

作者信息

  • 1. 成都蓉生药业有限责任公司,四川 成都 610200
  • 折叠

摘要

目的 通过全面比较2 家国内厂家(B、C)与1 家国外厂家(A)的药用辅料麦芽糖质量、过滤效果,并作为静注人免疫球蛋白产品辅料对产品质量进行可比性研究,确定不同厂家麦芽糖作为静注人免疫球蛋白辅料的可行性和可替代性.方法 对不同厂家麦芽糖进行质量检验和质量比对、进行小规模过滤试验、静注人免疫球蛋白(pH4)生产后产品质量进行可比性研究.结果 比对结果发现,国内厂家B与国外厂家A药用级麦芽糖质量上无显著差异,生产的静注人免疫球蛋白(pH4)质量上也无显著性差异.国内厂家C质量不符合要求.结论 国内厂家B与国外厂家A生产的药用级麦芽糖质量无统计学差异,可用于静注人免疫球蛋白(pH4)的生产.

Abstract

Objective To comprehensively compare the quality and filtration efficiency of medicinal maltose between two domestic manufacturers(B,C)and one foreign manufacturer(A),compare their product quality as an excipient for in-travenous immunoglobulin(IVIG),so as to determine the feasibility and substitutability of maltose as an excipient for IVIG from different manufacturers.Methods Quality inspection and comparison of maltose from different manufacturers,small-scale filtration tests,and product quality comparision of IVIG(pH4)were conducted.Results The comparis on results showed that there was no significant difference in the quality of medicinal maltose between manufacturer B and A,and there was no significant difference in the quality of IVIG(pH4)produced.The quality of manufacturer C did not meet the require-ments.Conclusion There is no significant difference in the quality of medicinal maltose produced by manufacturer B and A,which can be used for the production of IVIG(pH4).

关键词

静注人免疫球蛋白(IVIG)/麦芽糖/质量分析

Key words

intravenous immunoglobulin(IVIG)/maltose/quality analysis

引用本文复制引用

出版年

2024
中国输血杂志
中国输血协会 中国医学科学院输血研究所

中国输血杂志

CSTPCD
影响因子:1.279
ISSN:1004-549X
参考文献量17
段落导航相关论文